Results 11 to 20 of about 65,545 (257)
Direct oral anticoagulants uptake and an oral anticoagulation paradox [PDF]
Oral anticoagulation (OAC) for stroke prevention in patients with atrial fibrillation is underutilised. One of the impediments to warfarin therapy is the frequent monitoring required, usually at a specialised warfarin clinic. The advent of direct oral anticoagulants (DOACs) facilitates OAC therapy without an onerous monitoring regimen. This benefit may
Cormac Kennedy +4 more
openaire +2 more sources
Background: The benefits and risks of starting anticoagulation therapy, such as direct oral anticoagulations (DOACs) or warfarin, in atrial fibrillation (AF) patients with a history of intracranial hemorrhage (ICH) remain controversial.
Qiang Zhou +6 more
doaj +1 more source
Objective: Oral anticoagulation is a standard of care for thromboembolic stroke prevention in individuals with atrial fibrillation (AF). Social determinants of health have had limited investigation in AF and particularly in access to anticoagulation.
Toluwa D. Omole +8 more
doaj +1 more source
Much new evidence on oral anticoagulation has come to light in recent years. Non-vitamin-K-dependent oral anti- coagulants (NOAC) have been developed and have been introduced into clinical practice. In this review, we present the current state of the evidence on anticoagulation for various indications with vitamin K antagonists (VKA) and with NOAC.This
Ertunc, Altiok, Nikolaus, Marx
openaire +2 more sources
Oral anticoagulation – current knowlegde
Vitamin K antagonists (VKA) and direct oral anticoagulants (DOAC) are two groups of drugs used in the prevention of thromboembolic events. Although DOACs are currently the preferred option in such prophylaxis, there are still indications for the use of ...
Anna Karaś +4 more
doaj +1 more source
Objective During the first wave of the SARS-CoV-2 pandemic, management of anticoagulation therapy in hospitalized patients with atrial fibrillation (AF) was simplified to low-molecular-weight heparin (LMWH) followed by oral anticoagulation, mainly owing ...
Pável Olivera +9 more
doaj +1 more source
Left ventricular thrombus is a known complication following acute myocardial infarction that can lead to systemic thromboembolism. To obviate the risk of thromboembolism, the patient needs anticoagulation in addition to dual antiplatelet therapy. However,
Akshyaya Pradhan +6 more
doaj +1 more source
Novel oral anticoagulants [PDF]
Oral anticoagulants have been used widely for the treatment of venous thromboembolism and stroke prevention. The vitamin K antagonists (VKAs), such as warfarin, have been around for the last 65 years and its efficacy as thromboprophylaxis remained largely unchallenged, at least until recently.
C W, Khoo +3 more
openaire +2 more sources
A CMAJ letter[1][1] from a “little cheese” family physician about new oral anticoagulants versus warfarin, and the response[2][2] from three “big cheese” academic specialists show that readers and authors of guidelines do not always agree.
Thomas L, Perry +4 more
openaire +2 more sources
Objectives:. Practices regarding anticoagulation use in coronavirus disease 2019 focus primarily on its efficacy in the critically ill without a clear understanding of when to begin anticoagulation. We sought to understand the association of preinfection
Raquel F. Harrison, MD +8 more
doaj +1 more source

